Related Experiment Video
Updated: Oct 12, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Kaifu Gao1, Rui Wang1, Jiahui Chen1
1Department of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States.
Journal of Medicinal Chemistry
|November 20, 2021
Summary
This study reviews 817 SARS-CoV-2 main protease inhibitors, analyzing their mechanisms, activity, and druggability. It highlights challenges and future directions for developing effective COVID-19 treatments targeting the viral Mpro.
Area of Science:
- * Virology and Drug Discovery
- * Medicinal Chemistry and Pharmacology
Background:
- * The SARS-CoV-2 main protease (Mpro) is essential for viral replication and a key therapeutic target.
- * Current drug development for COVID-19 is lengthy, with no approved medications yet.
Purpose of the Study:
- * To compile and analyze a comprehensive list of SARS-CoV-2 and SARS-CoV Mpro inhibitors.
- * To evaluate their molecular mechanisms, structure-activity relationships (SARs), antiviral activity, and druggability.
Main Methods:
- * Literature and database compilation of 817 Mpro inhibitors.
- * Analysis of molecular mechanisms, SARs, antiviral data, ADMET properties, and animal study results.
Main Results:
- * Detailed review of 817 SARS-CoV and SARS-CoV-2 Mpro inhibitors.
- * Discussion of SARs, antiviral efficacy, ADMET profiles, and animal model data.
- * Identification of druggability and limitations for potential therapeutics.
Conclusions:
- * The study provides a comprehensive overview of existing Mpro inhibitors.
- * It offers insights into the development of novel inhibitors for SARS-CoV-2 and future coronavirus diseases.
Related Concept Videos
01:29Subviral Agents
188
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
188
02:50Conjugated Proteins
20.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
20.6K
01:30Enzyme Inhibition
83.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
83.5K
01:23Dipeptidyl Peptidase 4 Inhibitors
289
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
289
01:28Antimicrobial Effectiveness
386
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
386